Pascale André - Concepedia

Author

Pascale André

Also Known As

Andre, Pascale, N. Boucherit, P ANDRE, P Andre, P André, P. Andre, P. André, Pascale Andre, Pascale André, Pascale André

112

Publications

8.6K

Citations

H-Index

Concepts

All Affiliations

Innate Pharma (France)Inserm Centre d’Immunologie de Marseille-Luminy Centre National de la Recherche Scientifique Assistance Publique Hôpitaux de Marseille

About

Pascale André is an author at Innate Pharma (France) specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	17	2.6K
2	Natural Sciences	2	2	101
3	Health Sciences	1	1	12
4	Allergy	1	1	1.1K
5	Biochemistry	1	1	50

Pascale André

Publications

6.7K

Citations

H-Index

Page 1

	Year	Citations
Human NK Cell Education by Inhibitory Receptors for MHC Class I Nicolas Anfossi, Pascale André, Sophie Guia, Immunity Autoimmune DiseaseAllergyMhc ClassImmunologyImmunologic Mechanism	2006	1.1K
Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity Émilie Mamessier, Aude Sylvain, Marie‐Laure Thibult, Journal of Clinical Investigation Breast OncologyImmunologyImmune RegulationNk CellsImmunoediting	2011	666
Association of COVID-19 inflammation with activation of the C5a–C5aR1 axis Julien Carvelli, Olivier Demaria, Frédéric Vely, Nature	2020	528
Profound Coordinated Alterations of Intratumoral NK Cell Phenotype and Function in Lung Carcinoma Sophia Platonova, Julien Cherfils‐Vicini, Diane Damotte, Cancer Research	2011	475
Identification, activation, and selective<i>in vivo</i>ablation of mouse NK cells via NKp46 Thierry Walzer, Mathieu Bléry, Julie Chaix, Proceedings of the National Academy of Sciences	2007	450
Preclinical characterization of 1-7F9, a novel human anti–KIR receptor therapeutic antibody that augments natural killer–mediated killing of tumor cells François Romagné, Pascale André, Pieter Spee, Blood	2009	388
NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines Nadine van Montfoort, Linda Borst, Michael Korrer, Cell Tumor ImmunologyCancer ImmunosurveillanceImmunologyTumor ImmunityAutoimmunity	2018	317
Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies Holbrook E. Kohrt, Ariane Thielens, Aurélien Marabelle, Blood	2013	274
A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission Norbert Vey, Jean Bourhis, Nicolas Boissel, Blood	2012	268
A phase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myeloma Don M. Benson, Craig C. Hofmeister, Attaya Suvannasankha, Blood	2012	236

Page 1